Deprescribing here is done through one service, the Independent Medication Review: one doctor, your whole list, and the same clinical reasoning that was used to start each drug, applied again to decide whether to continue, reduce or stop it.
Deprescribing is not simply stopping tablets. It is a structured review of indication, benefit, risk, alternatives, monitoring, and follow-up. Medication changes should always be coordinated with your usual doctor where appropriate.
Consultations are in person in Sutton Coldfield, twenty minutes from Birmingham by train and about an hour and a half from London.
Investigations are charged separately.
People accumulate medications during stressful years (illness, weight gain, poor sleep, menopause, a difficult season) and then never get a clean reassessment once things improve.
The GP who added the medication has moved on. The specialist who started it discharged you. The repeat prescription just keeps printing.
If you have tried to stop something before and it went badly, that is usually the method, not you. Stopping a medicine well is a clinical skill, and it is rarely taught.
This review exists for the patient who wants one doctor to look at the whole picture.
Deprescribing is the careful reduction or stopping of medications that may no longer be helping, or may now be causing more harm than benefit.
It is not anti-medicine. It is medicine done properly.
When a medication is started, a clinical decision is made: the benefit outweighs the risk for this patient, now. That calculation changes over time. Weight changes. Blood pressure changes. Lifestyle changes. A medication started under one set of circumstances may no longer be indicated under different ones.
The review asks the same question that should have been asked at every repeat: is this still the right decision for this patient today?
"Sometimes the outcome is continue, with reassurance and a clear reason. Sometimes it is adjust, reduce, or stop, with a plan and monitoring. The decision is always personalised and safety-led."
Dr Dan Reardon · NHS A&E Doctor · GMC 6098984Deprescribing is the planned, supervised reduction or stopping of medications that may no longer be appropriate. It is the clinical counterpart to prescribing: applying the same risk-benefit analysis that was used to start a drug, to decide whether it should continue.
Most medications are started during a specific clinical moment: a diagnosis, an acute episode, a period of poor health. The decision to start is usually well-reasoned. The problem is that the review rarely happens. Weight changes. Blood pressure normalises. The original indication resolves. The prescription continues on a repeat, unchanged, sometimes for years.
Deprescribing does not mean stopping everything. Often the outcome is to continue, with reassurance and a documented clinical reason. But when a medication's benefit no longer outweighs its risk, or when it has never been formally reviewed since it was started, the clinical duty is to question it.
In the UK, deprescribing is supported by NICE guidance, the King's Fund polypharmacy review, and NHS England's structured medication review framework. It is mainstream clinical practice. It is simply not available at the pace or depth that patients deserve in a standard GP appointment.
The Independent Medication Review goes through everything you take. Each group of medicines has its own rebound pattern and its own way of being reduced, and this is what the review considers for each.
Whether the dose that was right then is still right now, especially after weight loss or a change in fitness. Step-down with home readings, one change at a time.
What the review considers → On amlodipine specifically →A slow taper, planned around sleep, stress and the risk of relapse, with the difference between withdrawal and relapse worked out in advance.
What the review considers →Often started for a bad patch and still there years later. A slow, planned reduction: your GP writes each step, I plan it and watch it with you.
The Independent Medication Review →Whether the pain it was started for is still the pain you have, what it is doing for you now, and a reduction plan where the balance has shifted. Your GP writes each step; the plan and the monitoring come from me.
The Independent Medication Review →Planning for rebound reflux, finding what triggers it, and stepping down rather than stopping dead.
What the review considers for omeprazole →For primary prevention, what the benefit is for you specifically, what the trade-offs are, and the case for continuing or stopping.
What the review considers →Whether the original reason for starting it was sound is a question very few patients have ever been invited to ask.
What the review considers →One plan, from one doctor, that covers the whole list: what interacts with what, what matters most, and what order to do things in. This is what the review is built for.
The Independent Medication Review →Medication changes are individual. They require review, planning, monitoring, and follow-up. This is what that looks like.
History, current medications, relevant results, side effects, and what has changed since the prescription was first written.
Is the medication still indicated? What is the risk-benefit balance now? What does stopping, reducing, or continuing actually mean for you specifically?
A personalised taper plan: gradual, responsive, with clear monitoring points and decision rules for what to do if symptoms change.
Liaison with your GP or specialist where appropriate. If the plan needs watching while you carry it out, supervised step-down is there for that.
Medication changes should never be made abruptly without clinical supervision. Every plan is built around safety first.
Not a recommendation to look things up. A written, personalised plan, with the reasoning for every decision in it.
Continue, adjust, reduce, or stop, with the clinical reasoning documented clearly.
Where deprescribing is appropriate, a specific, stepwise schedule with timeframes and decision points.
What to watch for, at what intervals, and what would justify changing the plan.
What to expect and what to do if withdrawal or rebound symptoms emerge.
A written summary to your GP where appropriate, keeping your care coordinated.
Clear markers for review and a pathway back if something changes.
"My job is to review the whole picture, then build a safe step-down plan you can actually follow."
Book the reviewMost private clinics are set up to prescribe. This one is set up to review. The commercial incentive points in a different direction, and that matters when the question is whether to stop a medication, not start one.
Dr Dan Reardon is an NHS A&E doctor. Frontline emergency medicine gives a particular view of what happens downstream when medication management goes wrong: polypharmacy, missed indications, undertreated withdrawal. That experience shapes every review.
Not ideological. Not anti-medication. Clinically serious about getting the decision right.
Evidence-led guides on stopping specific medications: what happens, when to worry, and what a proper plan looks like.
The Independent Medication Review gives you a written plan for what should change and what shouldn't.